Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis

American Journal of Medicine

Volumn 119, Issue 10, 2006, Pages 812-819

  Galassi, Andrea ^a   Reynolds, Kristi ^a   He, Jiang ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Meta analysis; Metabolic syndrome

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MEDLINE; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLE SIZE; STROKE; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PROSPECTIVE STUDIES; RISK FACTORS; TERMINOLOGY;

EID: 33748776056     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.02.031     Document Type: Article

References (35)

1. Reaven G.M. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Trevisan M., Liu J., Bashas F.B., and Menotti A. Syndrome X and mortality: a population based study; risk factor and life expectancy research group. Am J Epidemiol 148 (1998) 958-966
3. Wilson P.W., Kannel W.B., Silbershatz H., and D'Agostino R.B. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159 (1999) 1104-1109
4. Gray R.S., Fabsitz R.R., Cowan L.D., et al. Risk factor clustering in the insulin resistance syndrome. The strong heart study. Am J Epidemiol 148 (1988) 869-878
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
6. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization. Available at: http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf. Accessed October 19, 2004.
7. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
8. Hu G., Qiao Q., Tuomilehto J., et al. Prevalence of metabolic syndrome and its relation to all cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
9. Malik S., Wong D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United Stated adults. Circulation 110 (2004) 1245-1250
10. Sattar N., Graw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
11. Katzmarzyk P.T., Church T.S., and Blair S.N. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med 164 (2004) 1092-1097
12. Holvoet P., Kritchevsky S.B., Tracy R.P., et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53 (2004) 1068-1073
13. Kip K.E., Marroquin O.C., Kelley D.E., et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 109 6 (2004) 706-713
14. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
15. Onat A., Ceyhan K., Basar O., et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002) 285-292
16. Schillaci G., Pirro M., Vaudo G., et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 19 43 (2004) 1817-1822
17. Resnick H.E., Jones K., Ruotolo G., et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26 (2003) 861-867
18. Rutter K.M., Meigs J.B., Sullivan M.L., et al. C-Reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring study. Circulation 110 (2004) 380-385
19. Hunt K.J., Resendez R.G., Williams K., et al. National cholesterol education program versus world health organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart study. Circulation 110 (2004) 1251-1257
20. Anderson J.L. Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?. Cardiology 101 (2004) 185-193
21. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study. Diabetes Care 28 (2005) 385-390
22. Gimeno Orna J.A., Lou Arnal L.M., Molinero Herguedas E., et al. Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes. [Spanish]. Rev Esp Cardiol 57 (2004) 507-513
23. Bruno G. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes. The Casale Monferrato Study. Diabetes Care 27 (2004) 2689-2694
24. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
25. Bonora E., Targher G., Formentini G., et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 21 (2004) 52-58
26. Bonora E., Kiechl S., Willeit J., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26 (2003) 1251-1257
27. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-cause: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173 (2004) 309-314
28. Girman C.J., Rhodes T., Mercuri M., et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93 (2004) 136-141
29. Der Simonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
30. Begg C.B. Publication Bias. In: Cooper H., and Hedges L.F. (Eds). The Handbook of Research Synthesis (1994), Russell Sage Foundation, New York, NY 399-409
31. Ruige J.B., Assendelft W.J., Dekker J.M., et al. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 97 (1998) 996-1001
32. Diercks G.F., van Boven A.J., Jillege J.L., et al. The importance of microalbuminuria as a cardiovascular risk indicator: a review. Can J Cardiol 18 (2002) 525-535
33. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
34. Einhorn D., Reaven G.M., Cobin R.H., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9 (2003) 237-252
35. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed November 18, 2005.